Characteristics and prognosis of hearing loss associated with vogt-koyanagi-harada disease

Audiology and Neurotology

Volumn 19, Issue 1, 2014, Pages 49-56

  Morita, Shinya ^a   Nakamaru, Yuji ^a   Obara, Nobuyuki ^a   Masuya, Masayori ^a   Fukuda, Satoshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Audiogram; Corticosteroid; Hearing loss; Prognosis; Vogt Koyanagi Harada disease

Indexed keywords

PREDNISOLONE;

ADULT; ARTICLE; AUDIOMETRY; AUDITORY THRESHOLD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; EYE INFLAMMATION; FEMALE; HEARING IMPAIRMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PURE TONE AUDIOMETRY; RETROSPECTIVE STUDY; TREATMENT DURATION; VOGT KOYANAGI SYNDROME; ADOLESCENT; AGE; AGED; MENINGOENCEPHALITIS; MIDDLE AGED; PATHOPHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AUDIOMETRY, PURE-TONE; FEMALE; HEARING LOSS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; UVEOMENINGOENCEPHALITIC SYNDROME; YOUNG ADULT;

EID: 84893142721     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000356386     Document Type: Article

References (25)

1. Ardic FN, Aktan S, Kara CO, Sanli B: High-frequency hearing and reflex latency in patients with pigment disorder. Am J Otolaryngol 1998; 19: 365-369.
2. Aydogan K, Turan OF, Onart S, Karadogan SK, Tunali S: Audiological abnormalities in patients with vitiligo. Clin Exp Dermatol 2006; 31: 110-113.
3. Barrenas ML, Axelsson A: The development of melanin in the stria vascularis of the gerbil. Acta Otolaryngol 1992; 112: 50-58.
4. Chee SP, Jap A, Bacsal K: Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore. Am J Ophthalmol 2009; 147: 154e1-161e1.
5. Gates GA, Mills JH: Presbycusis. Lancet 2005; 366: 1111-1120.
6. Helzner EP, Cauley JA, Pratt SR, Wisniewski SR, Zmuda JM, Talbott EO, de Rekeneire N, Harris TB, Rubin SM, Simonsick EM, Tylavsky FA, Newman AB: Race and sex differences in age-related hearing loss: the Health, Aging and Body Composition Study. J Am Geriatr Soc 2005; 53: 2119-2127.
7. Hilding DA, Ginzberg RD: Pigmentation of the stria vascularis: the contribution of neural crest melanocytes. Acta Otolaryngol 1977; 84: 24-37.
8. International Organization for Standardization: Acoustics: statistical distribution of hearing thresholds as a function of age, ISO 7029. 2000. http://www.iso.org.
9. Kitamura M, Takami K, Kitaichi N, Namba K, Kitamei H, Kotake S, Ohno S: Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada's disease. Am J Ophthalmol 2005; 139: 1080-1085.
10. Lai TYY, Chan RPS, Chan CKM, Lam DSC: Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye (Lond) 2009; 23: 543-548.
11. Mazzoli M, van Camp G, Newton V, Giarbini N, Declau F, Parving A: Recommendations for the description of genetic and audiological data for families with nonsyndromic hereditary hearing impairment. Audiol Med 2003; 1: 148-150.
12. McGinness J, Corry P, Proctor P: Amorphous semiconductor switching in melanins. Science 1974; 183: 853-855.
13. Miyanaga M, Kawaguchi T, Shimizu K, Miyata K, Mochizuki M: Influence of early cerebrospinal fluid-guided diagnosis and early highdose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease. Int Ophthalmol 2007; 27: 183-188.
14. Mondkar SV, Biswas J, Ganesh SK: Analysis of 87 cases with Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 2000; 44: 296-301.
15. Moorthy RS, Inomata H, Rao NA: Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995; 39: 265-292.
16. Nelson EG, Hinojosa R: Presbycusis: a human temporal bone study of individuals with downward sloping audiometric patterns of hearing loss and review of the literature. Laryngoscope 2006; 116: 1-12.
17. Niparko JK, Wang NY, Rauch SD, Russell GB, Espeland MA, Pierce JJ, Bowditch S, Masuda A, Gulya AJ, Gantz BJ, Hughes GB, Brookhouser PE, Hannley MT, Telian SA, Harris JP, AIED Study Group: Serial audiometry in a clinical trial of AIED treatment. Otol Neurotol 2005; 26: 908-917.
18. Ondrey FG, Moldestad E, Mastroianni MA, Pikus A, Sklare D, Vernon E, Nusenblatt R, Smith J: Sensorineural hearing loss in Vogt-Koyanagi-Harada syndrome. Laryngoscope 2006; 116: 1873-1876.
19. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M: Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001; 131: 647-652.
20. Rubsamen PE, Gass JD: Vogt-Koyanagi-Harada syndrome: clinical course, therapy and longterm visual outcome. Arch Ophthalmol 1991; 109: 682-687.
21. Solaro C, Messmer Uccelli M: Intravenous methylprednisolone for aseptic meningitis in Vogt-Koyanagi-Harada syndrome. Eur Neurol 2000; 44: 129-130.
22. Steel KP, Barkway C: Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear. Development 1989; 107: 453-463.
23. Sugita S, Takase H, Taguchi C, Imai Y, Kamoi K, Kawaguchi T, Sugamoto Y, Futagami Y, Itoh K, Mochizuki M: Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci 2006; 47: 2547-2554.
24. World Health Organization: Global burden of hearing loss in the year 2000. http://www.who. int/healthinfo/statistics/bod-hearingloss. pdf.
25. Wasterstrom SA, Bredberg G, Lindquist NG, Lyttkens L, Rask-Anderson H: Ototoxicity of kanamycin in albino and pigmented guinea pigs. I. A morphologic and electrophysiologic study. Am J Otol 1986; 7: 11-18.